AbbVie (ABBV): Buy, Sell, or Hold Post Q4 Earnings?
Over the past six months, AbbVie has been a great trade, beating the S&P 500 by 5.6%. Its stock price has climbed to $233.25, representing a healthy 11.2% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
